[We] will likely see profound changes going forward in treatment of cardiometabolic disorders and diabetes in the future and the treatment and prevention of obesity, noting this study was among diabetics only, he said
Based on the mechanism of action and phase 2 results in obese patients and type 2 diabetes patients, I agree and expect CagriSema to generate 24-27% weight loss
That is why we recommend solutions that work with biology instead of fighting it
At Perfect B in Doral, that supervised, measured philosophy is how we approach every peptide conversation, and you can see the framework on our supervised peptide therapy program built around assessment, protocol design, and monitoring
Lifestyle adjustments like these are worth making in order to help minimize changes, even if they typically arent enough on their own to prevent issues entirely in patients with rapid or significant weight loss
Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial
